Both univariate and multivariate COX regression analysis showed that the increased mortality in adult AML patients was significantly associated with over 60 years old, cytogenetics, DNMT3A positive mutation, TP53 positive mutation, treatment type (chemotherapy), and high TSC22D3 expression (P < 0.05) (See Table 3). Here, TP53 is linked to acute myeloid leukemia.